Blog

Recent Trends in Chimeric Antigen Receptor (CAR) Macrophages for Cancer Immunotherapy

Download the full article (PDF)     Introduction CAR-macrophage therapy is an emerging cancer treatment strategy that engineers macrophages to express chimeric antigen receptors (CARs), redirecting their natural tumor-homing, phagocytic, and immune-activating functions against cancer. Unlike CAR-T cells, which primarily kill through cytotoxicity, CAR-macrophages are designed to infiltrate solid tumors, engulf cancer cells, and remodel […]

Recent Trends in Chimeric Antigen Receptor (CAR) Macrophages for Cancer Immunotherapy

Recent Articles​

Diagram showing CAR-Treg cell engineering process with regulatory T cell, chimeric antigen receptor, and final CAR-Treg product for autoimmune disease treatment
Assay Development

The CAR-Treg Rebellion

Download the full article (PDF)   MarinBio BLOG The CAR-Treg Rebellion Chimeric Antigen Receptor (CAR)-engineered regulatory T cells (CAR-Tregs) represent a distinct and rapidly emerging frontier in cellular immunotherapy, offering

Read More »

Recent Articles